The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
Conditions: Lung Cancer; Liver Cancer; Pancreatic Cancer; Renal Cell Carcinoma Interventions: Radiation: SBRT Sponsors: Peking University Third Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Kidney Cancer | Liver | Liver Cancer | Lung Cancer | Pancreas | Pancreatic Cancer | Renal Cell Carcinoma | Research | Urology & Nephrology